These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20522711)

  • 21. Antibody-mediated resolution of light chain-associated amyloid deposits.
    Hrncic R; Wall J; Wolfenbarger DA; Murphy CL; Schell M; Weiss DT; Solomon A
    Am J Pathol; 2000 Oct; 157(4):1239-46. PubMed ID: 11021828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo.
    Hawkins PN
    Clin Sci (Lond); 1994 Sep; 87(3):289-95. PubMed ID: 7955904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.
    Wall JS; Richey T; Stuckey A; Donnell R; Macy S; Martin EB; Williams A; Higuchi K; Kennel SJ
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E586-94. PubMed ID: 21807994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.
    Mekinian A; Jaccard A; Soussan M; Launay D; Berthier S; Federici L; Lefèvre G; Valeyre D; Dhote R; Fain O;
    Amyloid; 2012 Jun; 19(2):94-8. PubMed ID: 22587492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.
    Richards DB; Cookson LM; Berges AC; Barton SV; Lane T; Ritter JM; Fontana M; Moon JC; Pinzani M; Gillmore JD; Hawkins PN; Pepys MB
    N Engl J Med; 2015 Sep; 373(12):1106-14. PubMed ID: 26176329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN; Lavender JP; Pepys MB
    N Engl J Med; 1990 Aug; 323(8):508-13. PubMed ID: 2377176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.
    Lee SP; Suh HY; Park S; Oh S; Kwak SG; Kim HM; Koh Y; Park JB; Kim HK; Cho HJ; Kim YJ; Kim I; Yoon SS; Seo JW; Paeng JC; Sohn DW
    J Am Coll Cardiol; 2020 Feb; 75(4):380-390. PubMed ID: 32000949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and monitoring of amyloidosis.
    Hawkins PN
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
    Hawkins PN; Richardson S; MacSweeney JE; King AD; Vigushin DM; Lavender JP; Pepys MB
    Q J Med; 1993 Jun; 86(6):365-74. PubMed ID: 8171184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R; Deveaux M; Hachulla E; Descamps J; Duquesnoy B; Marchandise X
    Eur J Nucl Med; 1993 Feb; 20(2):130-7. PubMed ID: 8440269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
    Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
    Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis
    Renz M; Torres R; Dolan PJ; Tam SJ; Tapia JR; Li L; Salmans JR; Barbour RM; Shughrue PJ; Nijjar T; Schenk D; Kinney GG; Zago W
    Amyloid; 2016 Sep; 23(3):168-177. PubMed ID: 27494229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients.
    Arbustini E; Merlini G; Gavazzi A; Grasso M; Diegoli M; Fasani R; Bellotti V; Marinone G; Morbini P; Dal Bello B
    Am Heart J; 1995 Sep; 130(3 Pt 1):528-36. PubMed ID: 7661071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
    Hawkins PN; Aprile C; Capri G; Viganò L; Munzone E; Gianni L; Pepys MB; Merlini G
    Eur J Nucl Med; 1998 Jul; 25(7):701-8. PubMed ID: 9662591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel styrylbenzene derivatives for detecting amyloid deposits.
    Nakazono M; Obayashi K; Sasamoto K; Tomiyoshi K; Suenaga G; Ando Y
    Clin Chim Acta; 2014 Sep; 436():27-34. PubMed ID: 24815035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of agents for targeting visceral amyloid.
    Wall JS; Solomon A; Kennel SJ
    Tijdschr Nucl Geneeskd; 2011 Dec; 33(4):807-814. PubMed ID: 23885194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Histological and immunohistochemical examinations in the diagnosis of hepatic amyloidosis].
    Mikhaleva LM; Gioeva ZV; Rёken K
    Arkh Patol; 2015; 77(4):11-16. PubMed ID: 26485775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis.
    Hazenberg BP; van Rijswijk MH; Lub-de Hooge MN; Vellenga E; Haagsma EB; Posthumus MD; Jager PL
    J Nucl Med; 2007 Jun; 48(6):865-72. PubMed ID: 17504868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visualization of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET/CT scan.
    Mekinian A; Ghrenassia E; Pop G; Roberts S; Prendki V; Stirnemann J; Weinmann P; Fain O
    Clin Nucl Med; 2011 Jan; 36(1):52-3. PubMed ID: 21157212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.